Jacob Johnsen Selected Research

6- cyano- 4- (N- ethylsulfonyl- N- methylamino)- 3- hydroxy- 2,2- dimethylchromane

1/2020

Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel Inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacob Johnsen Research Topics

Disease

10	Ischemia 01/2020 - 06/2013
6	Infarction (Infarctions) 01/2020 - 06/2013
5	Reperfusion Injury 01/2021 - 06/2013
1	Thrombosis (Thrombus) 07/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022
1	familial type 2 Hemiplegic migraine 01/2022
1	Migraine Disorders (Migraine) 01/2022
1	Heart Failure 01/2022
1	Diabetes Mellitus 01/2020
1	Hyperglycemia 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 11/2017
1	Hypertrophy 01/2017
1	Right Ventricular Hypertrophy 01/2017
1	Ventricular Tachycardia 01/2017
1	Ventricular Remodeling 01/2017
1	Pulmonary Arterial Hypertension 01/2017
1	Myocardial Infarction 01/2017

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2014
1	AnticoagulantsIBA 07/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	src-Family KinasesIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	GlycogenIBA 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2020
1	6- cyano- 4- (N- ethylsulfonyl- N- methylamino)- 3- hydroxy- 2,2- dimethylchromaneIBA 01/2020
1	methyl malonateIBA 01/2020
1	AcetylglucosamineIBA 01/2019
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2018
1	(4- ((5,6- diphenylpyrazin- 2- yl)(isopropyl)amino)butoxy)acetic acidIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Paroxetine (Paxil)FDA LinkGeneric 01/2017
1	Prostaglandins IIBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2017
1	treprostinil FDA Link 01/2017
1	Phosphodiesterase 5 InhibitorsIBA 11/2016
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2016
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 11/2016
1	Vardenafil Dihydrochloride (Levitra)FDA Link 11/2016
1	KT 5823IBA 11/2016
1	triphenyltetrazoliumIBA 04/2016
1	linopirdineIBA 04/2016
1	flupirtineIBA 04/2016
1	KCNQ Potassium ChannelsIBA 04/2016
1	Mitochondrial Permeability Transition PoreIBA 01/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014
1	WortmanninIBA 01/2014
1	EnzymesIBA 06/2013
1	AlloxanIBA 06/2013
1	AzaserineIBA 06/2013
1	O-GlcNAc transferaseIBA 06/2013

Therapy/Procedure

1	Percutaneous Coronary Intervention 07/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2022
1	Catheters 04/2016
1	Tourniquets 03/2016
1	Ischemic Postconditioning 01/2014